Health
Meta-analysis links cefepime to higher mortality than other beta-lactams
UCLA experts call finding a 'signal, not a verdict'
1
Sep 10
· 14d ago · 1 article · 1 source · development 1 of 4
Daniel Uslan and Ethan Smith of UCLA's David Geffen School of Medicine published an accompanying editorial cautioning that the trials generating the signal bear limited resemblance to contemporary practice. They cited recent trials including ACORN, which showed no significant mortality difference between cefepime and piperacillin-tazobactam, and other studies where cefepime showed lower mortality than comparators.
NY Post
“This is a signal, not a verdict… the trials that generate this signal bear limited resemblance to contemporary practice.”
Daniel Uslan, MD, and Ethan Smith, PharmD
Zahra Sohani, MD, PhD Lead researcher, Hôpital Maisonneuve-Rosemont Daniel Uslan, MD UCLA infectious disease expert Ethan Smith, PharmD UCLA pharmacist Dr. Marc Siegel Fox News senior medical analyst
The whole story articles
the bright band is this development · numbered dots are the others · click one to jump
Peak 2 pieces in 4h at Sep 10, 10 AM; 9 pieces over 14 days (9 articles)
Sep 10, 10 AM — 2 pieces · 2 articles — Newswires 1, Google News 1 Sep 10, 2 PM — quiet Sep 10, 6 PM — quiet Sep 10, 10 PM — quiet Sep 11, 2 AM — quiet Sep 11, 6 AM — quiet Sep 11, 10 AM — quiet Sep 11, 2 PM — quiet Sep 11, 6 PM — quiet Sep 11, 10 PM — quiet Sep 12, 2 AM — quiet Sep 12, 6 AM — quiet Sep 12, 10 AM — quiet Sep 12, 2 PM — quiet Sep 12, 6 PM — quiet Sep 12, 10 PM — quiet Sep 13, 2 AM — quiet Sep 13, 6 AM — quiet Sep 13, 10 AM — quiet Sep 13, 2 PM — quiet Sep 13, 6 PM — quiet Sep 13, 10 PM — quiet Sep 14, 2 AM — quiet Sep 14, 6 AM — 2 pieces · 2 articles — Google News 2 Sep 14, 10 AM — quiet Sep 14, 2 PM — quiet Sep 14, 6 PM — quiet Sep 14, 10 PM — quiet Sep 15, 2 AM — quiet Sep 15, 6 AM — quiet Sep 15, 10 AM — quiet Sep 15, 2 PM — quiet Sep 15, 6 PM — 2 pieces · 2 articles — Google News 1, Newswires 1 Sep 15, 10 PM — quiet Sep 16, 2 AM — quiet Sep 16, 6 AM — 1 piece · 1 article — Google News 1 Sep 16, 10 AM — 2 pieces · 2 articles — Newswires 1, Google News 1 Sep 16, 2 PM — quiet Sep 16, 6 PM — quiet Sep 16, 10 PM — quiet Sep 17, 2 AM — quiet Sep 17, 6 AM — quiet Sep 17, 10 AM — quiet Sep 17, 2 PM — quiet Sep 17, 6 PM — quiet Sep 17, 10 PM — quiet Sep 18, 2 AM — quiet Sep 18, 6 AM — quiet Sep 18, 10 AM — quiet Sep 18, 2 PM — quiet Sep 18, 6 PM — quiet Sep 18, 10 PM — quiet Sep 19, 2 AM — quiet Sep 19, 6 AM — quiet Sep 19, 10 AM — quiet Sep 19, 2 PM — quiet Sep 19, 6 PM — quiet Sep 19, 10 PM — quiet Sep 20, 2 AM — quiet Sep 20, 6 AM — quiet Sep 20, 10 AM — quiet Sep 20, 2 PM — quiet Sep 20, 6 PM — quiet Sep 20, 10 PM — quiet Sep 21, 2 AM — quiet Sep 21, 6 AM — quiet Sep 21, 10 AM — quiet Sep 21, 2 PM — quiet Sep 21, 6 PM — quiet Sep 21, 10 PM — quiet Sep 22, 2 AM — quiet Sep 22, 6 AM — quiet Sep 22, 10 AM — quiet Sep 22, 2 PM — quiet Sep 22, 6 PM — quiet Sep 22, 10 PM — quiet Yesterday, 2 AM — quiet Yesterday, 6 AM — quiet Yesterday, 10 AM — quiet Yesterday, 2 PM — quiet Yesterday, 6 PM — quiet Yesterday, 10 PM — quiet Today, 2 AM — quiet Today, 6 AM — quiet
◂ 1 earlier 2 3 4
Sep 11 Sep 12 Sep 13 Sep 14 Sep 15 Sep 16 Sep 17 Sep 18 Sep 19 Sep 20 Sep 21 Sep 22 now · 8:52 AM ET
Reported in the same hours
no headline names this development itself — these 1 claim were published in its stretch
first by jamanetwork.com , 13d ago
All 4 developments of Meta-analysis links cefepime to higher mortality than other… →
Newswires Google News